Rising Short Interest In Pharmacyclics, Other Biotechs (AMGN, GILD, PCYC)
December 26, 2013 at 13:26 PM EST
Among leading biotech and emerging pharmaceutical companies, the number of shares sold short in Amgen (NASDAQ: AMGN ), Gilead Sciences (NASDAQ: GILD ) and Pharmacyclics (NASDAQ: PCYC ) grew by the largest percentages between the November 29 and December 13 settlement dates. Medivation saw its short interest increase
